BioVenture Voices Episode 37: SR One's Simeon George
- Mar 23
- 1 min read
Simeon George discusses his early days at SR One while it was part of GSK, and the transition to making the firm independent in 2020. Plus, the importance of peer-to-peer collaboration, and his how he thinks about investing in different indications and modalities.
Chapters
Intro and early life - 0:43
Hopkins and early work - 6:41
Joining SR One - 14:45
2007 to 2020 / GSK - 23:51
Going independent - 27:49
2020 to present - 33:45
Peer-to-peer collaboration - 41:13
Therapeutics areas and modalities - 44:48
Investment outlook - 54:21
.png){kind=logo}